Dec 20 (Reuters) - Bausch Health Companies Inc BHC.TO :
* EYEGATE PHARMACEUTICALS - ON DEC 14, RECEIVED A NOTICE OF TERMINATION FROM BAUSCH HEALTH IRELAND LIMITED & VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L
* EYEGATE PHARMACEUTICALS - RECEIVED A NOTICE NOTIFYING BAUSCH HEALTH WILL VOLUNTARILY TERMINATE LICENSE AGREEMENT DATED JULY 9, 2015 - SEC FILING
* EYEGATE PHARMACEUTICALS - RECEIVED NOTICE NOTIFYING THAT BAUSCH HEALTH WILL VOLUNTARILY TERMINATE LICENSE AGREEMENT DATED FEB 21, 2017
* EYEGATE PHARMACEUTICALS - FOLLOWING TERMINATION OF AGREEMENTS, CO WILL REGAIN ALL RIGHTS TO EGP-437 THAT HAD BEEN LICENSED TO BAUSCH HEALTH
* EYEGATE-CO TO ALSO BE REIMBURSED BY BAUSCH HEALTH FOR CERTAIN OUT-OF-POCKET COSTS INCURRED IN CONNECTION WITH DEVELOPMENT WORK PURSUANT TO AGREEMENTS